Search

Your search keyword '"DANIEL PELLA"' showing total 183 results

Search Constraints

Start Over You searched for: Author "DANIEL PELLA" Remove constraint Author: "DANIEL PELLA"
183 results on '"DANIEL PELLA"'

Search Results

1. A Multi-Biomarker Approach to Increase the Accuracy of Diagnosis and Management of Coronary Artery Disease

3. Regional differences in physicians’ behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study

4. Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

5. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

6. The possible role of machine learning in detection of increased cardiovascular risk patients – KSC MR Study (design)

8. The role of physical activity and miRNAs in the vascular aging and cardiac health of dialysis patients

9. European survey on national harmonization in clinical research

10. Rare Presentation of Left Lower Lobe Pulmonary Artery Dissection

11. Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

12. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex

13. High Exogenous Antioxidant, Restorative Treatment for Prevention of Heart Failure: The Heart Diet

14. PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation

15. Potato consumption is associated with total and cause-specific mortality: a population-based cohort study and pooling of prospective studies with 98,569 participants

16. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

17. List of contributors

18. Western diets and risk of non-communicable diseases

20. Pre-heart failure at 2D- and 3D-speckle tracking echocardiography: A comprehensive review

21. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

22. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP)

23. Establishing a national biobank. Biobanking infrastructure initiative in Slovakia - Public policy, legal and ethical issues

24. Corrigendum to '2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk' [Atherosclerosis 290 (2019) 140–205]

25. Erratum to '2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk' [Atherosclerosis 290 (2019) 140–205]

26. European survey on national training activities in clinical research

27. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

28. The role of physical activity and miRNAs in the vascular aging and cardiac health of dialysis patients

29. Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in Slovakia

30. Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

31. Roma Ethnicity and Sex-Specific Associations of Serum Uric Acid with Cardiometabolic and Hepatorenal Health Factors in Eastern Slovakian Population: The HepaMeta Study

32. What is the Role of the Horizontal Transmission of Hepatitis B Virus Infection in Young Adult and Middle-Aged Roma Population Living in the Settlements in East Slovakia?

33. Apolipoprotein B/Apolipoprotein A-I Ratio Is a Better Predictor of Cancer Mortality Compared with C-Reactive Protein: Results from Two Multi-Ethnic US Populations

34. Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP)

35. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

36. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

37. Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients

38. Extended consensus on blood pressure variability beyond blood pressure for management of hypertension

39. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

40. P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel

41. P6229Potato consumption is associated with total and cause-specific mortality: a population-based cohort study and pooling of prospective studies with 73,717 participants

42. Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials

43. Effects of Diet and Nutrients on Epigenetic and Genetic Expressions

44. Effects of Nuts Consumption on Cardiometabolic Diseases and Cancer

45. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

46. Modern Eggs, Not Wild Type Eggs, Predispose Risk of Cardiovascular Disease, Diabetes and Cancer?

47. Fats and Oils for Health Promotion and Disease Prevention

48. List of Contributors

49. Functional Food Security for Prevention of Diabetes Mellitus

50. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Catalog

Books, media, physical & digital resources